On World Schizophrenia Day, we advocate to improve mental health services and policies that prioritize the needs of individuals with schizophrenia. Together, we can promote acceptance, raise awareness, and drive positive change. To learn more about schizophrenia, visit the World Health Organization’s website: https://lnkd.in/denEuwP
About us
Indivior is a global pharmaceutical company working to help change patients’ lives by developing medicines to treat substance use disorder and serious mental illnesses. Our vision is that all patients around the world will have access to evidence-based treatment for the chronic conditions and co-occurring disorders of addiction. Indivior is dedicated to transforming addiction from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of opioid dependence treatments, Indivior has a pipeline of product candidates designed to both expand on its heritage in this category and potentially address other chronic conditions and co-occurring disorders of addiction, including alcohol use disorder. Headquartered in the United States in Richmond, VA, Indivior employs more than 1000 individuals globally and its portfolio of products is available in 37 countries worldwide. Our guiding principles foster a corporate culture of trust, innovation, and a pioneering spirit: • Focus on patient needs to drive decisions • Seek the wisdom of the team • Believe that people’s actions are well intended • Care enough to coach • See it, own it, make it happen • Demonstrate honesty and integrity at all times Community guidelines: https://bit.ly/43QuKrw
- Website
-
http://www.indivior.com
External link for Indivior
- Industry
- Pharmaceutical Manufacturing
- Company size
- 501-1,000 employees
- Headquarters
- Richmond, VA
- Type
- Public Company
- Specialties
- Opioid use disorder, Alcohol use disorder, Rescue Medications, and Schizophrenia
Locations
-
Primary
.
Richmond, VA, US
-
.
Slough, GB
-
.
Hull, GB
-
.
Ft. Collins, CO, US
Employees at Indivior
Updates
-
During National Prevention Week, we come together to promote evidence-based prevention initiatives. At Indivior, helping those with substance use disorders is at the heart of everything we do. Let’s educate, advocate and take action for healthier communities. To learn more about National Prevention Week visit: https://lnkd.in/esPtaAj #NationalPreventionWeek24
-
On National Fentanyl Awareness Day, we honor the memory of those lost to fentanyl overdoses by taking steps to prevent future tragedies. According to Centers for Disease Control and Prevention, there have been over 73,000 reported deaths involving synthetic opioids across the U.S. in the 12-month period ending in Nov 2023*. Our mission has never been more critical, with millions being impacted by opioid use disorder and the opioid overdose epidemic. Through our work, Indivior is addressing addiction and overdose, providing a path to long-term recovery. We call on everyone to learn more about the risks associated with fentanyl and promote safety. To learn more visit: https://lnkd.in/e55Z7hv5 Let’s work toward a future free from fentanyl-related harm. #NationalFentanylAwarenessDay #NFAD #JustSayKNOW *Source: https://lnkd.in/e5Kcs_d
-
During Mental Health Awareness Month, let’s start conversations and spread awareness about the vital role mental health plays in overall health and well-being. Together, we can create supportive and understanding communities that connect individuals with addiction and co-occurring mental health disorders to the helpful resources they need to thrive. For more information on ways to find support, visit SAMHSA’s resource center: https://lnkd.in/gYCs3KAj #MentalHealthAwarenessMonth #MHAM2024 #MentalHealthMatters #TakeAMentalHealthMoment
-
News for #investors and #media: Indivior announces Q1 2024 financial results. Please read the press release here: https://lnkd.in/eN3Ewz3T
-
Let’s raise awareness about the risks associated with alcohol use disorder this Alcohol Awareness Month. Together, we can build safer and healthier communities. To learn more about the effect of alcohol on one’s health visit the National Institute on Alcohol Abuse and Alcoholism’s website: https://lnkd.in/gYrUeF7
-
We are pleased to share that Cindy Cetani, Indivior’s Chief Integrity and Compliance Officer, was voted in by her peers as a new member of Pharmaceutical Compliance Forum’s Board of Trustees! Join us in congratulating Cindy on joining the 2024 PCF Board! Pharmaceutical Compliance Forum (PCF) is a not-for profit 501(c)(6) company-based association for pharmaceutical compliance and legal professionals. PCF has been dedicated to the advancement of the pharmaceutical compliance profession since 1999. To learn more visit: pharmacomplianceforum.org
-
During National Drug and Alcohol Facts Week®, or NDAFW, it’s important to highlight the harsh realities of the ongoing opioid epidemic in America. According to the CDC, more than one million people have died since 1999 from a drug overdose with an increasing number of those deaths being attributed to fentanyl and other synthetic opioids.* As part of our mission, we’re helping to combat the opioid crisis by improving access to evidence-based treatment for those suffering from substance use disorder, serious mental illness or in need of opioid overdose rescue. To learn more about National Drug and Alcohol Facts Week visit NIDA’s website: https://lnkd.in/eYv79YgT *Drug Overdose Deaths | Drug Overdose | CDC Injury Center https://lnkd.in/eidCNhkB, CDC Vital Statistics Rapid Release - Provisional Drug Overdose Data https://lnkd.in/e5Kcs_d
-
We are pleased to announce the publication of the Annual Report and Accounts 2023. The theme of the report is “Transforming Lives.” You’ll see the theme woven throughout the publication to help showcase the impact Indivior’s work had on patients and the communities we served in 2023. Read more here: www.indivior.com